seminar 1 staphylococcus, streptococcus

Page 2: Staphylococcus Aureus

  • Name: Golden Staff of Moses

  • Genus Features:

    • Gram-positive

    • Cocci shape in clusters

    • Catalase positive

    • Small yellow colonies on blood agar

    • Beta-hemolytic

    • Coagulase positive

    • Ferments mannitol on mannitol salt agar

  • Reservoir:

    • Normal flora of nasal mucosa (25% of population carriers)

    • Skin

  • Transmission:

    • Hands, sneezing, surgical wounds

    • Contaminated foods (e.g., custard pastries, potato salad, canned meats)

  • Predisposing Factors for Infection:

    • Surgery/wounds

    • Foreign bodies (e.g., tampons, surgical packing, sutures)

    • Severe neutropenia, IV drug abuse, chronic granulomatous disease, cystic fibrosis

  • Disease and Pathogenesis:

    • Protein A inhibits phagocytosis

    • Diseases:

      • Gastroenteritis (food poisoning):

        • Toxin preformed in food; symptoms appear 2-6 hours after ingestion

        • Symptoms: nausea, abdominal pain, vomiting, diarrhea

      • Acute Infective Endocarditis:

        • Often from IV drug abuse; right-sided heart infection

        • Symptoms: fever, malaise, leukocytosis, heart murmur

      • Toxic Shock Syndrome:

        • Symptoms: fever, hypotension, scarlatiniform rash (desquamation)

        • TSST-1 superantigen causes cytokine storm

      • Osteomyelitis:

        • Bone pain, fever, redness; lytic bone lesions

      • Pneumonia:

        • Not leading cause; occurs in individuals with viral illnesses

        • Symptoms: productive pneumonia, salmon-colored sputum

      • Abscesses and Mastitis:

        • Symptoms: tenderness, redness, swelling

      • Impetigo, Scalded Skin Syndrome:

        • Symptoms: diffuse epidermal peeling

      • Surgical Infections:

        • Fever, cellulitis, abscesses

  • Treatment:

    • Gastroenteritis is self-limiting

    • Penicillin (Nafcillin/Oxacillin as DOC due to resistance)

    • MRSA: vancomycin

    • VRSA/VISA: quinupristin/dalfopristin

Page 4: Staphylococcus Epidermidis and Saprophyticus

  • Genus Features:

    • Gram-positive

    • Catalase positive, coagulase negative

    • Gamma-hemolysis/no hemolysis

  • Staphylococcus Epidermidis:

    • Novobiocin-sensitive

    • Biofilm producer

    • Reservoir: Skin flora—can contaminate blood cultures

    • Disease Presentations:

      • Endocarditis (artificial heart valves)

      • Catheter infections

      • Prosthetic device infections

    • Treatment: Vancomycin

  • Staphylococcus Saprophyticus:

    • Novobiocin-resistant

    • Disease Presentation: UTIs in newly sexually active females

Page 6: Streptococcus Pyogenes (Group A)

  • Name: The Pie Genies’ Bakery

  • General Features:

    • Gram-positive cocci in chains

    • Catalase negative, beta-hemolytic

    • Encapsulated with hyaluronic acid capsule

    • Bacitracin sensitive, PYR positive

  • Reservoir: Human throat, skin

  • Transmission: Direct contact, respiratory droplets

  • Pathogenesis:

    • Hyaluronic acid is non-immunogenic

    • M-protein is antiphagocytic

    • Streptolysin O immunogenic; Streptolysin S not

    • Spreading factors:

      • Streptokinase and streptococcal DNAse

  • Diseases:

    • Pyoderma/Impetigo

    • Pharyngitis/Strep Throat

    • Cellulitis/Erysipelas

    • Scarlet Fever

    • Toxic Shock-Like Syndrome

    • Rheumatic Fever

    • Acute Glomerulonephritis

  • Laboratory Diagnosis:

    • Rapid strep test (ELISA-based)

    • Culture all negatives

  • Treatment: Penicillin (macrolides for allergies)

  • Prevention: Prophylactic antibiotics post-acute RF

Page 8: Streptococcus Agalactiae (Group B)

  • Name: A Galactic Baby

  • General Features:

    • Gram-positive, catalase negative

    • Beta-hemolytic, bacitracin resistant

    • Hydrolyzes hippurate, encapsulated

    • CAMP test positive

  • Reservoir: Human vagina and GI tract (15-20% of women)

  • Transmission: Newborns infected during birth

  • Diseases:

    • Neonatal septicemia, meningitis, pneumonia

  • Treatment: Ampicillin with aminoglycoside or cephalosporin

  • Prevention: Prophylaxis during delivery in at-risk women.